# A Pharmacokinetic And QT Study Of CP-751,871 In Healthy Subjects

> **NCT00926263** · PHASE1 · TERMINATED · sponsor: **Pfizer** · enrollment: 28 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** CP-751,871
- **BIOLOGICAL:** CP-751,871
- **BIOLOGICAL:** CP-751,871, moxifloxacin, saline

## Key facts

- **NCT ID:** NCT00926263
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2013-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00926263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00926263, "A Pharmacokinetic And QT Study Of CP-751,871 In Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00926263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*